Hyaluronic Acid Based Dermal Fillers Market Forecasts to 2028 – Global Analysis By Crosslinking Type (Biphasic, Monophasic and Other Crosslinking Types), Product (Single Phase, Duplex Product and Other Products) and Others

Hyaluronic Acid Based Dermal Fillers Market Forecasts to 2028 – Global Analysis By Crosslinking Type (Biphasic, Monophasic and Other Crosslinking Types), Product (Single Phase, Duplex Product and Other Products) and Others

According to Stratistics MRC, the Global Hyaluronic Acid Based Dermal Fillers Market is accounted for $4.26 billion in 2022 and is expected to reach $7.43 billion by 2028 growing at a CAGR of 9.7% during the forecast period. Hyaluronic acid is a polymer substance that is naturally produced in the human body. These fillers are used to treat the skin disorders. It helps in anti ageing, smoothing of skin texture, correcting wrinkles, skin resilience, repair discoloration and skin cell regeneration. These fillers are launched for young people who are concerned about maintaining beauty standards. It has moisturizing and visco elastic capability. They are biodegradable and implants high longetivity.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), hyaluronic acid based dermal fillers were among the top 5 nonsurgical procedures around the globe, recording 4.3 million procedures.

Market Dynamics:

Driver:

Surging demand for flawless and youthful skin

Beautiful skin doesn't happen by chance, it takes some work. So, people started using the products which helps in anticipating the youthful skin. These dermal fillers help in giving soft, supple, smooth and rich with cells skin. It helps in preventing wrinkling and ageing. The demand for youthful skin is driving the market rapidly.

Restraint:

Presence of substitute dermal fillers

The invention of topical products such as wrinkle creams, facial implants and grafting substituted the dermal fillers which restraints the growth of the market. Non-invasive collagen stimulation process and minimally invasive skin resurfacing methods are the major impact on the dermal fillers market. These fillers replace the volume and price which restricts the growth.

Opportunity:

Increasing trend of minimally invasive surgeries

Simply persistent surgeries became popular as the operating techniques are less pain and faster recovery after an operation. The patients can return to work quickly. It decreases pain and increases the range of motion. It decreases the risk of complications such as wound dehiscence, incisional hernia and bowel adhesions and more acceptable to patients.

Threat:

Lack of skilled professionals

Skilled dermatologists and plastic surgeons are required to perform dermal filer surgery. Treatment by the unprofessional surgeons may cause bleeding disorders or some allergies. If the surgery fails the skin should face a lot of sagging. Improper injection technique can lead to serious side effects such as death of skin cells and embolism leading to blindness.

Covid-19 Impact

The demand for hyaluronic acid declined, as it has major applications in elective procedures, due to COVID-19 restrictions, especially during the early stages of the pandemic. Moreover, patients opted out or postponed procedures even in later stages of the pandemic to avoid the risk of infection, which negatively impacted the industry, resulting in a decline in the overall revenue easing of pandemic restrictions across the world, a higher preference for injection-based elective procedures has been observed over surgeries, which is expected to boost hyaluronic acid market post-pandemic.

The single phase segment is expected to be the largest during the forecast period

The single phase segment is estimated to have a lucrative growth. Single-phase products are widely employed for a variety of skin-related applications to address abnormalities in the soft face tissues since the uncross-linked HA increases elastin and collagen production, making the skin appear more youthful and healthier.23-Sept-2022

The osteoarthritis segment is expected to have the highest CAGR during the forecast period

The osteoarthritis segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in the geriatric population and an increasing preference for minimally invasive procedures. It is used to treat certain allergies and infections in your knee or in the skin around your knee.

Region with highest share:

North America is projected to hold the largest market share during the forecast period owing to higher number of minimally invasive cosmetic surgeries performed in the region. This is due to the presence of a sizeable base of the geriatric population, which is more susceptible to disorders, such as osteoarthritis, vesicoureteral reflux, and cataracts.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to growing awareness about applications of dermal fillers in emerging economies and increasing disposable income levels. The growing demand for minimally invasive cosmetic surgeries and applications of hyaluronan and its efficiency fuels the growth of the market.

Key players in the market

Some of the key players profiled in the Hyaluronic Acid Based Dermal Fillers Market include Allergan plc, Pharvaris Netherlands B.V, Ionis Pharmaceuticals, Inc, Candela Medical, Inc, KalVista Pharmaceuticals Ltd, Anika Therapeutics, Inc, BioCryst Pharmaceuticals, Inc, Merz Pharma GmbH & Co. KGaA, Bioxis Pharmaceuticals SAS, BioPlus Co., Ltd, Galderma Laboratories L.P, Prollenium Medical Technologies Inc, Teoxane SA, Cynosure LLC, LG life sciences, Genzyme Corporation, Sculpt Luxury Dermal Filters Ltd, Sinclair Pharma, Laboratories Vivacy, DR. Korman, Inamed Corporation, Suneva Medical, Bohus biotech AB, BIOHA Laboratories, Vivacy Laboratories

Key Developments:

In February 2022, Allergan received FDA approval for JUVÉDERM VOLUMA XC in adults over the age of 21 to improve infra orbital hollows.

In December 2019, Anika Therapeutics launched its first hyaluronic acid-based surgically delivered regenerative therapy, TACTOSET, in the U.S. for the treatment of bone defects caused by trauma or degeneration.

Crosslinking Types Covered:
• Biphasic
• Monophasic
• Other Crosslinking Types

Products Covered:
• Single Phase
• Duplex Product
• Other Products

Applications Covered:
• Lip Enhancements
• Volume/ Fullness Restoration
• Scar Treatment
• Wrinkle Correction Treatment
• Rhinoplasty
• Osteoarthritis
• Vesicoureteral Reflux
• Ophthalmic
• Dermal Fillers
• Other Applications

End Users Covered:
• Specialty And Dermatology Clinics
• Hospitals
• Clinics
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements